Health & Medicine

February 1, 2013

Analyst: Stem cell agency reforms fall short

With little money and time left to repair its legacy, California's controversial stem cell agency is falling short in its response to a federal committee's recommendations for an overhaul, the committee's chair said Thursday.

Related content



Editor's Choice Videos